Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

GlucoSet

GlucoSet
2011 FOUNDED
M&A STATUS
11-20 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
3 INVESTORS
Description

Developer of health monitoring system designed to reduce harmful hypoglycemia. The company's real-time intravascular blood glucose monitoring system delivers continuous and accurate information on the patient's blood glucose level, enabling normalization of glucose levels, without the risk of sudden and dangerously low glucose levels.

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Distributors (Healthcare)
Parent Company
Primary Office
  • Sluppenvegen 6
  • 7037 Trondheim
  • Norway

+47 977 00 000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore GlucoSet’s full profile, request a free trial.

GlucoSet Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Buyout/LBO Completed Pre-Clinical Trials
2. Grant 24-Feb-2016 00.000 Completed Pre-Clinical Trials
1. Grant 17-Oct-2014 $24.7K Completed Pre-Clinical Trials
To view this company’s complete deal history including valuation and funding, request access »

GlucoSet Executive Team (5)

Name Title Board
Seat
Contact
Info
Nicolas Elvemo Chief Executive Officer
Parvinder Dhillon Chief Technology Officer
Reinold Ellingsen Ph.D Co-Founder & Board Member
Dag Hjelme Co-Founder

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »

GlucoSet Board Members (5)

Name Representing Role Since Contact
Info
Erik Fuglseth Ph.D Self Board Member 000 0000
Jan Sollid Self Chairman 000 0000
Jørgen Nilsen Televenture Board Member 000 0000
Kjell Ingebrigtsen Ph.D Self Board Member 000 0000
Reinold Ellingsen Ph.D GlucoSet Co-Founder & Board Member 000 0000